Federal contract award
W81XWH19C0181
BRAND NAME ARAKODA MALARIA PROPHYLACTIC DRUG TAFENOQUINE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $5.5M |
| Current contract value | $5.5M |
| Potential contract value / ceiling | $6.0M |
| Start date | Sep 1, 2019 |
| Current end date | Aug 31, 2022 |
| Potential end date | Aug 31, 2022 |
| Latest award activity | Jul 1, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 1, 2025 | P00008 | $-29.0K | BRAND NAME ARAKODA TAFENOQUINE |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.